Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samcyprone for Common Warts
NCT02640820Phase 2Unknown
- Sponsor
- Phio Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diphencyprone in common warts, sponsored by Phio Pharmaceuticals. Status: unknown.
02
Drugs
diphencyprone
03
Conditions
common warts
Beyond the preview
Go deeper on NCT02640820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640820.